Evolving Treatment Modalities for Management of Patients Suffering From Disc Displacement With Reduction

• Status: Not yet recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Aim of the current study is to compare the efficacy of Low Level Laser, Botulinum toxin type A, and repositioning appliance in management of reduced temporomandibular joint disc.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nourhan M.Aly
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A

Criteria

Inclusion Criteria:

• TMJ with audible and palpable click.

• Patients with anterior disc displacement as detected by MRI.

• Presence of full or nearly full complement of natural teeth.

Exclusion Criteria:

• Patients who have radiographic evidence of degenerative conditions of TMJ.

• Patients who have anterior disc dislocation without reduction.

• Previous history of TMD treatment.

• History of recent trauma.

• The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis).

• Inability or unwillingness to undergo magnetic resonance imaging (MRI) such as implanted electronic devices.

• Pregnant and lactating females.

• Patients with known allergy to botulinum toxin type A.

• Patients suffering from neurological disorders.